SIBN - NASDAQ
SI-BONE, Inc.
$14.84
+5.9%SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
At a Glance
Live Snapshotsibn
Cash and Cash Equivalents
Last Annual Value
42.24M
3-Year CAGR
27%
5-Year CAGR
-5%
10-Year CAGR
8%
SI-BONE, Inc. Competitors Analysis of Cash and Cash Equivalents
| Company | Cash and Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
SI-BONE, Inc. NASDAQ:SIBN | 42.24M | 8.3% | -7.8% | 4.2% | |
 Orthofix Medical Inc. NASDAQ:OFIX | 82.03M | 35.3% | -1.4% | 7.6% | |
 InnovAge Holding Corp. NASDAQ:INNV | 64.14M | 4.0% | -20.6% | N/A | |
 Butterfly Network, Inc. NYSE:BFLY | 150.49M | 3.8% | -18.7% | N/A | |
 Varex Imaging Corporation NASDAQ:VREX | 145.00M | -1.7% | 0.1% | N/A | |
 Anavex Life Sciences Corp. NASDAQ:AVXL | 102.58M | -12.1% | -7.6% | 27.3% | |
 Aquestive Therapeutics, Inc. NASDAQ:AQST | 121.17M | 71.9% | 34.0% | 29.4% | |
 ClearPoint Neuro, Inc. NASDAQ:CLPT | 45.92M | 25.7% | -3.2% | 30.1% | |
 Avanos Medical, Inc. NYSE:AVNS | 89.80M | 0.8% | -5.4% | -2.3% | |
 AirSculpt Technologies, Inc. NASDAQ:AIRS | 8.45M | -6.3% | -19.7% | N/A | |
 Pacific Biosciences of California, Inc. NASDAQ:PACB | 63.71M | -29.3% | -32.7% | 14.3% |
SI-BONE, Inc. Fair Value Envelope
Related Guides
Continue your SIBN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.